Clinical trial
The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT04964427 is registered in ClinicalTrials.gov with Bambino Gesù Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
- Lead sponsor
- Bambino Gesù Hospital and Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 8, 2021
- Completion date
- November 2, 2022
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder